Skip to main content
SCPX logo

Scorpius Holdings, Inc. (SCPX) Stock Price & Analysis

Scorpius Holdings, Inc. (SCPX) — price $0.0002 (0.00%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$0.0002 $0.00 (0.00%)

Scorpius Holdings, Inc. · SCPX

Scorpius Holdings Inc. operates as an integrated contract development and manufacturing organization (CDMO) through its subsidiary, Scorpius BioManufacturing. It offers a comprehensive suite of services, including analytical testing, process development, formulation, and clinical biomanufacturing, to pharmaceutical and biotechnology companies.

Price as of Nov 19, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • NVO · Novo Nordisk A/S · 87 /100
  • VRTX · Vertex Pharmaceuticals Incorporated · 90 /100
  • REGN · Regeneron Pharmaceuticals, Inc. · 95 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.0002
Change on the day0.00%
52-week range$0.0001 – $0.10
Shares traded on the day60.8K

Price & events

Other perspectives

Council score for Scorpius Holdings (SCPX): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Strong
ROE Weak
Gross Margin Negative

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Scorpius Holdings (SCPX), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Scorpius Holdings, Inc. (SCPX) is the company analyzed here. It employs 91 people and is led by Jeff A. Wolf. In Q3 FY2025 it reported revenue of $229,842 and net income of -$984,429.

2 · Latest results

What do the latest results show for Scorpius Holdings (SCPX)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $229,842. Against analyst estimates the company has EPS beat 2 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$229,842-$984,429-$0.02 (diluted)
Q2 FY2025$2M-$4M-$0.09 (diluted)
Q1 FY2025$212,264-$11M-$1.16 (diluted)
Q4 FY2024$1M-$9M-$1.85 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Scorpius Holdings (SCPX)?

Short answer · as of

The distress and quality screens read Piotroski F 0. Trailing ratios: ROE 0.0% · ROA -24.4% · current ratio 0.10.

Data-derived red flags

  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
4 · What to check next?

What should you watch next at Scorpius Holdings (SCPX)?

Short answer · as of

Analyst estimates on file carry FY2026 revenue $10.00M · EPS -342.00 · 1 analysts.

What the records here don't tell us

  • The next earnings date is not yet scheduled in the calendar we read.
  • Fewer than two score snapshots exist, so no score trend is shown.

Checked against the records this page reads, on the dates shown above.

The records behind this page

Analyst targets & estimates

What analysts have on file

Revenue estimate
$10.00M
EPS estimate
$-342.00

Measured against a quoted price of $0.0002 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
2
Identified insiders
1
Purchases
0
Sales
0
Other transactions
2

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held SCPX in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported SCPX in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Investor Questions: SCPX Stock

These answers are editorial: 1 of these 1 answer is drawn from the SCPX research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.

How does Scorpius Holdings, Inc. navigate the competitive CDMO landscape?

Scorpius Holdings, Inc. navigates the competitive CDMO landscape by offering an integrated service model that spans analytical testing, process development, formulation, and clinical biomanufacturing.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 8 from Financial Modeling Prep (FMP) and 9 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.